TP53 and cancer: Existing evidence showed that p53 downregulation or loss function was closely associated with CDDP resistance in numerous human cancers.[16, 17] Consistent with previous studies, our data showed that knockdown of p53 decreased the susceptibility of hepatoma cells to CDDP‐induced apoptosis (Figure S7A,B, Supporting Information).